Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent.
Saved in:
| Title: | Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. |
|---|---|
| Authors: | Shekar PV; Department of Plant and Environmental Sciences, Clemson University Pee Dee Research and Education Center, Florence, SC 29506, USA., Kumar A; Department of Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada.; Department of Pediatrics, IWK Health Center, Canadian Centre for Vaccinology CCfV, Halifax, NS B3H 4R2, Canada., Mulgaonkar N; Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX 77843, USA., Kashyap S; Department of Plant and Environmental Sciences, Clemson University Pee Dee Research and Education Center, Florence, SC 29506, USA., Choudhir G; Centre for Rural Development & Technology, Indian Institute of Technology (IIT), New Delhi 110016, India., Fernando S; Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX 77843, USA., Rustgi S; Department of Plant and Environmental Sciences, Clemson University Pee Dee Research and Education Center, Florence, SC 29506, USA.; School of Health Research, Clemson University, Clemson, SC 29634, USA.; Center for Human Genetics, Clemson University, Greenwood, SC 29646, USA. |
| Source: | Biomolecules [Biomolecules] 2025 Jun 01; Vol. 15 (6). Date of Electronic Publication: 2025 Jun 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
